Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Co-delivery of GOLPH3 siRNA and gefitinib by cationic lipid-PLGA nanoparticles improves EGFR-targeted therapy for glioma.

Ye C, Pan B, Xu H, Zhao Z, Shen J, Lu J, Yu R, Liu H.

J Mol Med (Berl). 2019 Nov;97(11):1575-1588. doi: 10.1007/s00109-019-01843-4. Epub 2019 Nov 14. Erratum in: J Mol Med (Berl). 2020 Jan 3;:.

PMID:
31673738
2.

Golgi phosphoprotein 3 sensitizes the tumour suppression effect of gefitinib on gliomas.

Wang X, Wang Z, Zhang Y, Wang Y, Zhang H, Xie S, Xie P, Yu R, Zhou X.

Cell Prolif. 2019 Jul;52(4):e12636. doi: 10.1111/cpr.12636. Epub 2019 May 16.

PMID:
31094020
3.

Inhibition of glioma growth by a GOLPH3 siRNA-loaded cationic liposomes.

Yuan Z, Zhao L, Zhang Y, Li S, Pan B, Hua L, Wang Z, Ye C, Lu J, Yu R, Liu H.

J Neurooncol. 2018 Nov;140(2):249-260. doi: 10.1007/s11060-018-2966-6. Epub 2018 Aug 13.

PMID:
30105446
4.

Golgi phosphoprotein 3 promotes glioma progression via inhibiting Rab5-mediated endocytosis and degradation of epidermal growth factor receptor.

Zhou X, Xie S, Wu S, Qi Y, Wang Z, Zhang H, Lu D, Wang X, Dong Y, Liu G, Yang D, Shi Q, Bian W, Yu R.

Neuro Oncol. 2017 Nov 29;19(12):1628-1639. doi: 10.1093/neuonc/nox104.

5.

Correction to: Co-delivery of GOLPH3 siRNA and gefitinib by cationic lipid-PLGA nanoparticles improves EGFR-targeted therapy for glioma.

Ye C, Pan B, Xu H, Zhao Z, Shen J, Lu J, Yu R, Liu H.

J Mol Med (Berl). 2020 Jan 3. doi: 10.1007/s00109-019-01871-0. [Epub ahead of print]

PMID:
31900504
6.

Co-delivery of doxorubicin and siRNA for glioma therapy by a brain targeting system: angiopep-2-modified poly(lactic-co-glycolic acid) nanoparticles.

Wang L, Hao Y, Li H, Zhao Y, Meng D, Li D, Shi J, Zhang H, Zhang Z, Zhang Y.

J Drug Target. 2015;23(9):832-46. doi: 10.3109/1061186X.2015.1025077. Epub 2015 Apr 9.

PMID:
25856302
7.

Protein kinase D2 promotes the proliferation of glioma cells by regulating Golgi phosphoprotein 3.

Zhou X, Xue P, Yang M, Shi H, Lu D, Wang Z, Shi Q, Hu J, Xie S, Zhan W, Yu R.

Cancer Lett. 2014 Dec 1;355(1):121-9. doi: 10.1016/j.canlet.2014.09.008. Epub 2014 Sep 16.

PMID:
25218347
8.

GOLPH3 promotes glioblastoma cell migration and invasion via the mTOR-YB1 pathway in vitro.

Zhang X, Ding Z, Mo J, Sang B, Shi Q, Hu J, Xie S, Zhan W, Lu D, Yang M, Bian W, Zhou X, Yu R.

Mol Carcinog. 2015 Nov;54(11):1252-63. doi: 10.1002/mc.22197. Epub 2014 Aug 23.

PMID:
25156912
9.

Angiopep-2 Modified Cationic Lipid-Poly-Lactic-Co-Glycolic Acid Delivery Temozolomide and DNA Repair Inhibitor Dbait to Achieve Synergetic Chemo-Radiotherapy Against Glioma.

Li S, Xu Q, Zhao L, Ye C, Hua L, Liang J, Yu R, Liu H.

J Nanosci Nanotechnol. 2019 Dec 1;19(12):7539-7545. doi: 10.1166/jnn.2019.16775.

PMID:
31196258
10.

Overexpression of Golgi phosphoprotein-3 (GOLPH3) in glioblastoma multiforme is associated with worse prognosis.

Zhou J, Xu T, Qin R, Yan Y, Chen C, Chen Y, Yu H, Xia C, Lu Y, Ding X, Wang Y, Cai X, Chen J.

J Neurooncol. 2012 Nov;110(2):195-203. doi: 10.1007/s11060-012-0970-9. Epub 2012 Sep 13.

PMID:
22972189
11.

Golgi Phosphoprotein 3 Promotes Wls Recycling and Wnt Secretion in Glioma Progression.

Lu D, Zhang H, Fu J, Qi Y, Wang X, Wu S, Zhou X, Yu R.

Cell Physiol Biochem. 2018;47(6):2445-2457. doi: 10.1159/000491618. Epub 2018 Jul 10.

12.

Expression of the Golgi phosphoprotein-3 gene in human gliomas: a pilot study.

Li XY, Liu W, Chen SF, Zhang LQ, Li XG, Wang LX.

J Neurooncol. 2011 Nov;105(2):159-63. doi: 10.1007/s11060-011-0573-x. Epub 2011 Apr 16.

PMID:
21499727
13.

GOLPH3 promotes glioma progression via facilitating JAK2-STAT3 pathway activation.

Wu S, Fu J, Dong Y, Yi Q, Lu D, Wang W, Qi Y, Yu R, Zhou X.

J Neurooncol. 2018 Sep;139(2):269-279. doi: 10.1007/s11060-018-2884-7. Epub 2018 Apr 30.

PMID:
29713848
14.

Brain tumor-targeted therapy by systemic delivery of siRNA with Transferrin receptor-mediated core-shell nanoparticles.

Wei L, Guo XY, Yang T, Yu MZ, Chen DW, Wang JC.

Int J Pharm. 2016 Aug 20;510(1):394-405. doi: 10.1016/j.ijpharm.2016.06.127. Epub 2016 Jun 29.

PMID:
27374198
15.

The knocking down of the oncoprotein Golgi phosphoprotein 3 in T98G cells of glioblastoma multiforme disrupts cell migration by affecting focal adhesion dynamics in a focal adhesion kinase-dependent manner.

Arriagada C, Luchsinger C, González AE, Schwenke T, Arriagada G, Folch H, Ehrenfeld P, Burgos PV, Mardones GA.

PLoS One. 2019 Feb 19;14(2):e0212321. doi: 10.1371/journal.pone.0212321. eCollection 2019.

16.

Investigation of enzyme-sensitive lipid nanoparticles for delivery of siRNA to blood-brain barrier and glioma cells.

Bruun J, Larsen TB, Jølck RI, Eliasen R, Holm R, Gjetting T, Andresen TL.

Int J Nanomedicine. 2015 Sep 24;10:5995-6008. doi: 10.2147/IJN.S87334. eCollection 2015.

17.

Co-administration of 20(S)-protopanaxatriol (g-PPT) and EGFR-TKI overcomes EGFR-TKI resistance by decreasing SCD1 induced lipid accumulation in non-small cell lung cancer.

Huang Q, Wang Q, Li D, Wei X, Jia Y, Zhang Z, Ai B, Cao X, Guo T, Liao Y.

J Exp Clin Cancer Res. 2019 Mar 15;38(1):129. doi: 10.1186/s13046-019-1120-4.

18.

Molecular mechanisms underlying effects of epidermal growth factor receptor inhibition on invasion, proliferation, and angiogenesis in experimental glioma.

Guillamo JS, de Boüard S, Valable S, Marteau L, Leuraud P, Marie Y, Poupon MF, Parienti JJ, Raymond E, Peschanski M.

Clin Cancer Res. 2009 Jun 1;15(11):3697-704. doi: 10.1158/1078-0432.CCR-08-2042. Epub 2009 May 12.

19.

Epidermal growth factor receptor and ligand family expression and activity in glioblastoma.

von Achenbach C, Weller M, Szabo E.

J Neurochem. 2018 Oct;147(1):99-109. doi: 10.1111/jnc.14538. Epub 2018 Aug 16.

20.

Golgi Phosphoprotein 3 Inhibits the Apoptosis of Human Glioma Cells in Part by Downregulating N-myc Downstream Regulated Gene 1.

Li X, Li M, Tian X, Li Q, Lu Q, Jia Q, Zhang L, Yan J, Li X, Li X.

Med Sci Monit. 2016 Oct 4;22:3535-3543.

Supplemental Content

Support Center